Braveheart Bio Logo (full size)
Braveheart Bio Logo icon/symbol
Braveheart Bio Logo (full size) on a dark background
Braveheart Bio Logo icon/symbol on a dark background
About Braveheart Bio
Braveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases. It develops and offers BHB-1893 and HRS-1893, an oral small-molecule cardiac myosin inhibitor (CMI) for the treatment of obstructive HCM and non-obstructive HCM. The company was incorporated in 2024 and is headquartered in San Francisco, California.
August 7th, 2026
